New Chemotherapeutic Agents for Non-small Cell Lung Cancer

This publication has 14 references indexed in Scilit:

• Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study.
  Journal of Clinical Oncology, 1994
• Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer.
  Journal of Clinical Oncology, 1994
• Phase I and pharmacokinetic trial of weekly CPT-11.
  Journal of Clinical Oncology, 1993
• Cisplatin-Cyclophosphamide-Mitomycin Combination Chemotherapy With Supportive Care Versus Supportive Care Alone for Treatment of Metastatic Non-Small-Cell Lung Cancer
  JNCI Journal of the National Cancer Institute, 1993
• Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group Results
  JNCI Journal of the National Cancer Institute, 1993
• A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.
  Journal of Clinical Oncology, 1991
• Phase II study of 10-ethyl-10-deaza-aminopterin (10-EdAM; CGP 30 694) for stage IIIB or IV non-small cell lung cancer
  Investigational New Drugs, 1990
• Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.
  Journal of Clinical Oncology, 1988
• Phase II study of 10-ethyl-10-deaza-aminopterin in patients with stage III and IV non-small-cell lung cancer.
  Journal of Clinical Oncology, 1988
• Promotion of microtubule assembly in vitro by taxol
  Nature, 1979